If your organization is one of the 52% of SAP customers whose top analytics pain point is data integration¹, Google Cloud has got you covered. By working with partners like Qlik, we are expanding our integration options and bringing real-time replication capability for SAP to BigQuery.

Integrated data for accelerated insights

BigQuery—our fully managed, enterprise data warehouse that can scale up to petabytes on demand and execute queries in seconds—allows SAP customers to consolidate enterprise data silos and confidently derive more use and value from their data.  Customers can accelerate and simplify the delivery of SAP data on BigQuery with the latest Qlik Data Integration platform offering for Google Cloud which allows data integration using an automated, near real-time data pipeline through Qlik Replicate, whether data originates from legacy SAP environments, SAP HANA, or SAP application servers. Additionally, Qlik Compose for Data Warehouses can be used to easily generate and automate logical data models from SAP directly in BigQuery freeing up more time for data analysts to leverage advanced built-in capabilities such as BigQuery ML to derive greater value and insights using standard SQL without the need for advanced programming expertise.

Delivering faster results with real-time 

Traditional extract-transform-load (ETL) solutions operate on a batch basis, pulling data sets from SAP daily, hourly, or every minute. These tools often require manual mapping of multiple data fields so that data flows accurately. Given SAP’s highly complex table relationships, in which a single transaction can result in multiple changes, this can be a time consuming and tedious process. ETL can also increase the burden on your SAP systems.

Qlik Replicate simplifies this with its intuitive user interface where you can set up real-time data replication between SAP and BigQuery, eliminating the need for manual coding. And, to prevent system overhead, as soon as a new transaction is entered into SAP, the resulting data is replicated into BigQuery in a process known as change data capture (CDC) from SAP’s log layer. This means that data transfer can benefit from high performance with minimal impact on the source system’s resources. Read our latest white paper to learn how to extract SAP data into BigQuery leveraging Qlik Replicate. 

Solution expertise for all core SAP workloads

It doesn’t matter what database your SAP system runs on, Qlik Replicate supports all core SAP systems. It automates real-time data replication and decodes SAP’s complex, application-specific data structures into formats that flow smoothly into BigQuery. This ensures that anyone who depends on data analytics has the most current and relevant SAP data they need. For its robust solution capabilities Qlik has received a new “SAP on Google Cloud Expertise” designation for supporting:

• Fast onboarding and accelerated replication of SAP data into Google Cloud
• Real-time and continuous data replication from SAP applications to BigQuery
• Support for all core SAP modules and a broad set of data sources
• Automated data integration, which cuts resource requirements for initial delivery and ongoing maintenance

Proven customer results

Many SAP customers have experienced the benefits of leveraging Qlik alongside BigQuery for data analytics and AI at scale, including German luxury department store chain Breuninger. In order to meet its customers’ growing and changing expectations,Breuninger needed to accelerate its time to insight from data sources across a highly dispersed landscape of on-premises databases and systems, including SAP. The company uses Qlik Replicate to feed corporate data from modules in its SAP system into BigQuery and integrate its varying on-premises databases with the Google Cloud environment. This has yielded game-changing, real-time customer insights for the retailer.

What could your business do with faster, more integrated insights? Learn more about BigQuery for SAP customers and also how Qlik and Google Cloud can help you modernize and automate data integration and analytics.

The COVID-19 pandemic continues to push the healthcare and life sciences industry in entirely new ways. In record time, we’ve witnessed public health officials, vaccine developers, equipment manufacturers, and essential workers take life saving actions—regularly putting their own lives at risk—to respond to the exceptional challenges of our time. 

Yet after all the turmoil and uncertainty of the pandemic, record breaking levels of investment continue to come into the market to fuel innovations. 

Vaccine development is now measured in weeks rather than years; providers are leveraging telehealth technologies to improve the physician and patient experience; and individuals have embraced a variety of devices to assume greater ownership and control of their personal health. 

With that in mind, here are five of the many innovations I see driving healthcare and life sciences for at least the next 12 months: 

1. Unleashing the power of healthcare and life sciences data

People have arguably never had as much access and understanding to their personal health data than they can in 2022. They have the ability to understand their genetic makeup, medical history, family history, and activity levels to ensure they are living a healthy lifestyle. Taken together, this longitudinal profile can become the basis for more personalized medicine. Add wearable devices to the mix and patients gain real- or near-real-time updates on their health status. 

Further, global regulatory agencies have continued to mandate the need for providers to maintain a longitudinal health record that provides a holistic view of the patient across all the encounters they have had with a health system. Physician surveys conducted by the The Harris Poll and Google Cloud show that a 360-degree view of the patient, across all provider encounters, leads to faster, more accurate diagnosis, and better outcomes. 

If secure data access and interoperability can begin to include insurers, researchers, public health officials, and others in the field, the powerful network effects benefiting patients will only grow. When combined with those longitudinal phenome profiles, the opportunities for personalized and preventative medicine enter a whole new era.

2. Healthcare and life sciences M&A boom continues

Although the pandemic initially slowed activity on mergers and acquisitions in the early part of 2020, the healthcare and life sciences industry has seen a rapid rebound and acceleration of deals ever since. The success of COVID-19 vaccines, the importance of telehealth, and the focus on molecular modeling and genomic-based drug development have all boosted investment as organizations look to enter new markets, develop new therapies, and leverage low interest rates while they last. 

In 2021, the total funding of US digital health startups surpassed $29 billion across 729 deals, according to advisory Rock Health. That’s almost double the levels of 2020, which itself set records. Analysts at PWC meanwhile estimate M&A investments in biopharmaceutical and life sciences could approach $400 billion this year across all sub-sectors

Clearly, the pandemic has been a primary driver of investment as the focus on healthcare has dramatically increased. Yet the increased activity also reflects changing business models and emerging technologies that are now required to compete in the rapidly evolving space. For organizations to capitalize on these investments, it will take not only great vision and intellectual property but also the right technologies—like cloud—and the right data interoperability models, to make partnerships and acquisitions more scalable, feasible, and seamless.

3. Transforming the patient experience at a new rate

The pandemic has shined a spotlight on the inefficiencies and complexities that exist in healthcare markets across the globe. As wave after wave has surged, global healthcare systems remain overwhelmed on most every aspect of patients’ treatment journeys. Even before COVID-19, healthcare was already one of the largest spend areas for governments around the world. The pandemic has only exacerbated the known issues. 

Clearly, administrators, regulators, physicians, nurses, and patients would agree that the processes and models need to change. There’s a need to maintain this momentum and even increase the tempo to achieve lasting change.

Take telehealth. Within months of the start of the pandemic, providers moved to provide more remote capabilities so physicians could still meet with patients virtually to ensure health and safety on all sides. Payers recognized the importance of telehealth and began to update reimbursement rules. And organizations are now reimagining policies in areas such as prior authorization, submission, and adjudication to reduce complexity and bureaucracy while improving responsiveness.

Looking beyond the system, organizations are also recognizing and deepening their understanding of the structural and social determinants of health that impact patient care and health outcomes, especially for historically underserved communities.  Private and public sectors are learning from, and increasingly partnering with, the social sciences, public health, biomedical informatics, computer science, public policy and community groups around how to build a mI’ore equitable and inclusive consumer products and Health IT strategies. 

The newfound levels of transparency, visibility, and accountability that patients, caregivers, and organizations are achieving will ultimately increase competition and provide a more effective, equitable, efficient and, above all, healthier marketplace for all patients. As we move past the worst of the pandemic, regulators and organizations should keep fighting for progress over business as usual.

4. AI is now a core competency for Drug Development

The ability of organizations like Pfizer, Moderna, Johnson & Johnson, and Astrazeneca to develop COVID-19 vaccines has been a remarkable accomplishment—particularly the historic speed with which they were created and deployed. This innovation acceleration was largely enabled by the use of new drug development platforms that allow researchers to use artificial intelligence and machine learning to model protein and cellular interactions to rapidly advance the science.

No longer must researchers rely on traditional laboratory testing (and retesting). With their improved understanding of the molecular and genetic structure of a patient and, for example, their tumor, researchers can use AI to enable simulations on computers rather than testing in live conditions. This technology can process thousands, even millions of simulations to help  identify high-potential candidates for treatment consideration and subsequent analysis. 

AI-enabled drug discovery models can eliminate months and years from the research process, which can reduce the time to develop a drug and accelerate the time to treatment for an individual patient. As just one example, consider the work on AlphaFold2 by Google’s DeepMind unit who leverages AI to predict effective protein shapes for new drugs. Healthcare and life sciences organizations already recognize the potential of AI. Now comes the investments to leverage this rapidly evolving technology to support their efforts now and in the future.   

5. Ecosystem partnerships tackle complexity and spur innovation

As the importance and growth of the healthcare and life sciences industry continues, we will see even more new players and partnerships emerging to address old problems in new ways. This trend will touch all aspects of the healthcare value chain and will, increasingly, see three- and four-player partnerships emerge to address the complex challenges of today’s healthcare marketplace.

Technology will continue to play a key role as capabilities and platforms will transform all aspects of the marketplace. Cell phones, wearable devices, and other technologies will provide real-time updates and notifications to patients on everything from glucose levels to payments for healthcare services. Voice recognition software will document physician and patient discussions to reduce the burden of record keeping. Real-world data will be used to simplify and confidentially recruit patients for participation in clinical trials. 

New players will continue to enter the market to improve health outcomes and reduce costs. Major retailers are among the companies extending their pharmacies to provide additional diagnostic and concierge services, saving patients from additional appointments while boosting prevention. Community organizations are emerging to help identify and care for underserved communities whose health outcomes are significantly lower than the average patient. 

For all the exhausting and heart-wrenching challenges of the past two years, the opportunities the pandemic has laid bare cannot be overlooked. We owe it to those who have worked and fought so hard for every life to forge even more new partnerships—and make it easier to do so—so that the next crisis, when it does arise, will never be as bad as the one we’re now conquering. Technology can be the enabler in this effort and help bring us together to continue to conquer the challenges that lie ahead.

In-memory data stores are a fundamental infrastructure for building scalable, high-performance applications. Whether it is building a highly responsive ecommerce website, creating multiplayer games with thousands of users, or doing real-time analysis on data pipelines with millions of events, an in-memory store helps provide low latency and scale for millions of transactions. Redis is a popular in-memory data store for use cases like session stores, gaming leaderboards, stream analytics, API rate limiting, threat detection, and more. Another in-memory data store, open source Memcached, continues to be a very popular choice as a caching layer for databases and is used for its speed and simplicity.

We’re announcing Memorystore for Memcached in beta, a fully managed, highly scalable service that’s compatible with the open source Memcached protocol. We launched Memorystore for Redis in 2018 to let you use the power of open source Redis easily without the burden of management. This announcement brings even more flexibility and choice for your caching layer. 

Highlights of Memorystore for Memcached

Memcached offers a simple but powerful in-memory key value store and is popular as a front-end cache for databases. Using Memcached as a front-end store not only provides an in-memory caching layer for faster query processing, but it can also help save costs by reducing the load on your back-end databases.

Using Memorystore for Memcached provides several important benefits:

• Memorystore for Memcached is fully open source protocol compatible. If you are migrating applications using self-deployed Memcached or other cloud providers, you can simply migrate your application with zero code changes.
• Memorystore for Memcached is fully managed. All the common tasks that you spend time on, like deployment, scaling, managing node configuration on the client, setting up monitoring, and patching, are all taken care of. You can focus on building your applications.
• Right-sizing a cache is a common challenge with distributed caches. The scaling feature of Memorystore for Memcached, along with detailed open source Memcached monitoring metrics, allows you to scale your instance up and down easily to optimize for your cache-hit ratio and price. With Memorystore for Memcached, you can scale your cluster up to 5 TB per instance.
• Auto-discovery protocol lets clients adapt to changes programmatically, making it easy to deal with changes to the number of nodes during scaling. This drastically reduces manageability overhead and code complexity.
• You can monitor your Memorystore for Memcached instances with built-in dashboards in the Cloud Console and rich metrics in Cloud Monitoring.

Memorystore for Memcached can be accessed from applications running on Compute Engine, Google Kubernetes Engine (GKE), App Engine Flex, App Engine Standard, and Cloud Functions.

The beta launch is available in major regions across the U.S., Asia, and Europe, and will be available globally soon.

Getting started with Memorystore for Memcached

To get started with Memorystore for Memcached, check out the quick start guide. Sign up for a $300 credit to try Memorystore and the rest of Google Cloud. You can start with the smallest instance and when you’re ready, you can easily scale up to serve performance-intensive applications. Enjoy your exploration of Google Cloud and Memorystore for Memcached.

Everyone wants affordable, quality healthcare but not everyone has it. A 2021 report by the Commonwealth Fund ranked the U.S. in last place among 11 high-income countries in healthcare access.1 Carbon Health is working to change that. We are doing so by combining the best of virtual care, in-person visits, and technology to support patients with their everyday physical and mental health needs.

Rethinking how data and analytics are accessed at Carbon Health

Delivering premium healthcare for the masses that’s accessible and affordable is an ambitious undertaking. It requires a commitment to operating the business in an efficient and disciplined way. To meet our goals, our teams across the company require detailed, daily insights into operating results.

In the last year, we realized our existing BI platform was inaccessible to most of our employees outside of R&D. Creating the analytics, dashboards, and reports needed by our clinic leaders and executives required direct help from our data scientists.

However, this has all changed since deploying Looker as our new BI platform. We initially used Looker to build tables, charts, and graphs that improved how people could access and analyze data about our operating efficiency. As we continued to evaluate how our data and analytics should be experienced by our in-clinic staff, we learned about Connected Sheets for Looker, which has unlocked an entirely new way of sharing insights across the company.

A new way to deliver performance reporting and drive results

Connected Sheets for Looker gives Carbon Health employees who work in Google Sheets—practically everyone—a familiar tool for working with Looker data. For instance, one of our first outputs using the Connected Sheets integration has been a daily and weekly performance push-report for the clinic’s operating leaders, including providers.

Essentially a scorecard, the report tracks the most important KPIs for measuring clinics’ successes, including appointment volume, patient satisfaction such as net promoter score (NPS), reviews, phone call answer rates, and even metrics about billing and collections. To provide easy access, we built a workflow through Google App Script that takes our daily performance report and automatically emails a PDF to key clinic leaders each morning.

Within the first 30 days of the report’s creation, clinic leaders were able to drive noticeable improvements in operating results. For instance, actively tracking clinic volume has enabled us to manage our schedules more effectively, which in turn drives more visits and enables us to better communicate expectations with our patients. Other clinics have dramatically improved their call answer rates by tracking inbound call volume, which has also led to better patient satisfaction.

Greater accountability, greater collaboration

As you can imagine, a report that holds people accountable for outcomes in such a visible way can create some anxiety. We’ve eased those concerns by using the information constructively, with the goal to use reporting as a positive feedback mechanism to bolster open collaboration and identify operational processes that need improvement. For example, data about our call answer rates initiated an investigation that led to an operational redesign of how phones are deployed and managed at more than 120 clinics across the U.S.

Looker as a scalable solution with endless applications

We’re now rolling out Connected Sheets for Looker to deliver performance push-reporting across all teams at Carbon Health. Additionally, we continue to find new ways to leverage Connected Sheets for Looker to meet other needs of the business.

For instance, we’ve recently been able to better understand our software costs by analyzing vendor spend from our accounting systems directly in Google Sheets. Going forward, this will allow us to build a basic workflow to monitor subscription spend and employee application usage, which will lead to us saving money on unnecessary licenses and underutilized software.

We’ve come a long way in the last year. Between Looker and its integration with Google Sheets, we can meet the data needs of all our stakeholders at Carbon Health. Connected Sheets for Looker has been an impactful solution that’s going to help us drive measurable results in how we deliver premium healthcare to the masses.

^{1. Mirror, Mirror 2021: Reflecting Poorly
2.  HEALTHCARE EDITORS’ PICK Meet The Immigrant Entrepreneurs Who Raised $350 Million To Rethink U.S. Primary Care}